Insulin-induced gene as therapeutic target in diabetes

Details Insulin-induced gene as therapeutic target in diabetes Insulin-induced gene as therapeutic target in diabetes

C - Chemistry, Metallurgy

12

Q

C12Q 1/68 (2006.01)

Patent

CA 2522552

The present invention relates to the use of a modulator of the expression or activity of the E21G4 gene for the treatment of diabetes or its complications, obesity or insulin resistance, to a method of screening compounds useful in the treatment of these pathological conditions, and to a method for the diagnosis or prognosis of these pathological conditions.

La présente invention porte sur l'utilisation d'un modulateur de l'expression de l'activité du gène E21G4 dans le traitement du diabète ou ses complications, l'obésité ou la résistance à l'insuline, et sur un procédé de criblage de composés utiles dans le traitement de ces états pathologiques, sur une méthode de diagnostic ou pronostic de ces états pathologiques.

Affiliated with

Also associated with

Rating

Insulin-induced gene as therapeutic target in diabetes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Insulin-induced gene as therapeutic target in diabetes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin-induced gene as therapeutic target in diabetes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1447931